Skip to main content

Table 1 Base line of patients enrolled in this study

From: The learning curve of the MS-TRAM/DIEP breast reconstruction by dual-trained breast surgeons

 

level

Overall n (%)

Patients

 

147 (100.0)

Neoadjuvant Chemotherapy (%)

No

76 (51.7)

Yes

62 (42.2)

NA

9 (6.1)

ER (%)

Negative

42 (28.6)

Positive

98 (66.7)

Unknown

7 (4.8)

PR(%)

Negative

56 (38.1)

Positive

85 (57.8)

Unknown

6 (4.1)

Her2 (%)

Negative

99 (67.3)

Positive

36 (24.5)

Unknown

12 (8.2)

cTNM-stage (%)

0

1 (0.7)

I

8 (5.4)

II

58 (39.5)

III

32 (21.8)

IV

38 (25.9)

Unknown

10 (6.8)

pTNM-stage (%)

0

5 (3.4)

I

21 (14.3)

II

35 (23.8)

III

35 (23.8)

IV

39 (26.5)

Unknown

12 (8.2)

Parity (%)

No

10 (6.8)

Yes

128 (87.1)

NA

9 (6.1)

Parity_times (%)

More than once

43 (29.3)

None

10 (6.8)

Once

56 (38.1)

NA

9 (6.1)

Type of surgery (Purpose) (%)

Reconstruction

106 (72.1)

Repair

41 (27.9)

Timing of breast reconstruction surgery (%)

Delayed

12 (8.2)

Immediate

133 (90.5)

Immediate-delayed

2 (1.4)

Type of the Breast Cancer Surgery (%)

(Modified) Radical Mastectomy

67 (45.6)

Nipple Sparing Mastectomy

25 (17.0)

Skin Sparing Mastectomy

55 (37.4)

Type of the Abdominal Free Flap (%)

DIEP

116(78.9)

ms-TRAM

26(17.7)

NA

5(3.4)

Type of Skin Leaving on the Flap (%)

Buried Flap

18 (12.2)

DIEP with Skin Paddle

129(85.7)

Microscope (%)

10X microscope

61(41.5)

3.5X loupes

86(58.5)

  1. Abbreviation: BMI, Body-mass index; IQR, inter-quartile range; ER, estrogen receptor; PR, progesterone receptor; HER2, human epidermal growth factor receptor 2; DIEP, deep inferior epigastric perforator; ms-TRAM, muscle-sparing free transverse rectus abdominal muscle; NA, Not Available